759916AD1
Repligen Corp
Could not find a ticker for this position, may be a filing error
A maker of tools and consumables for biologic drug manufacturing, Repligen supplies cell-retention filters, pre-packed columns, purification resins, and growth factors used by drugmakers worldwide. Founded in 1981 in Cambridge, Massachusetts, by two molecular biology professors, it focused entirely on bioprocessing starting in 2012. Its name blends "replication" and "genetics," a nod to its roots in recombinant protein science.
CONVERTIBLEUnderlying: RGENCUSIP: 759916AD1HealthcareUS1 derivative reporter
1.00% Convertible Senior Notes due December 15, 2028
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
